Illinois Ventures — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
cystetic Medicinescysteticmedicines.comNov 2020
Cystetic Medicines develops molecular prosthetics to treat cystic fibrosis, specifically targeting the 10% of CF patients who cannot benefit from existing modulator therapies due to little-to-no CFTR protein.
BiotechHealthtechMedical DevicesChampaign, US
PETER W STEELMAN(Director)JONATHAN RAMOS(Director)PETER B. FINN(Executive Officer)MARTIN BURKE, MD., PH.D.(Director)ZHENG SU(Director)Dr. Martin D. Burke(Co-founder)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.